Showing results (101-110 of 137) with videos related to

Sort By:
Pageof 14
BMJ (Clinical Research Ed.)|September 22, 2020
Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort studyOlivia V Swann, Karl A Holden, Lance Turtle, et al.
Nature|March 27, 2012
IFITM3 restricts the morbidity and mortality associated with influenzaAaron R Everitt, Simon Clare, Thomas Pertel, et al.
The Lancet. Microbe|April 9, 2023
Risk factors and vectors for SARS-CoV-2 household transmission: a prospective, longitudinal cohort studyNieves Derqui, Aleksandra Koycheva, Jie Zhou, et al.
The Lancet. Respiratory Medicine|May 17, 2021
Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UKAnnemarie B Docherty, Rachel H Mulholland, Nazir I Lone, et al.
The Lancet. Infectious Diseases|December 25, 2022
Clinical features and management of individuals admitted to hospital with monkeypox and associated complications across the UK: a retrospective cohort studyDouglas L Fink, Helen Callaby, Akish Luintel, et al.
Ebiomedicine|September 2, 2023
Effect of high-dose glucocorticoid treatment on human brown adipose tissue activity: a randomised, double-blinded, placebo-controlled cross-over trial in healthy menClaudia Irene Maushart, Wenfei Sun, Alaa Othman, et al.
BMJ Open|September 10, 2025
Observational study on the clinical epidemiology of infectious acute encephalitis syndrome including Nipah virus disease, Bangladesh: BASE cohort study protocolMd Zakiul Hassan, Amanda Rojek, Dewan Imtiaz Rahman, et al.
Plos Neglected Tropical Diseases|January 6, 2022
A standardised Phase III clinical trial framework to assess therapeutic interventions for Lassa feverAdebola Tolulope Olayinka, Josephine Bourner, George O Akpede, et al.
Eclinicalmedicine|October 19, 2023
Safety and efficacy of inhaled interferon-β1a (SNG001) in adults with mild-to-moderate COVID-19: a randomized, controlled, phase II trialPrasanna Jagannathan, Kara W Chew, Mark J Giganti, et al.
Medrxiv : the Preprint Server for Health Sciences|June 23, 2021
Molnupiravir, an Oral Antiviral Treatment for COVID-19William Fischer, Joseph J Eron, Wayne Holman, et al.
Pageof 14